期刊文献+

DSS、TNBS、OXZ诱导结肠炎动物模型的对比 被引量:11

Comparison of DSS,TNBS and OXZ-induced colitis in animal models
在线阅读 下载PDF
导出
摘要 目的对比研究DSS、TNBS、OXZ诱导的结肠炎动物模型。方法本研究选取了一般状态、DAI评分和组织学损伤评分几个方面来评价。结果 DSS组大鼠造模安全性较高,在整个实验过程中无大鼠出现死亡,而TNBS组及OXZ组均有2只大鼠出现死亡,DSS组大鼠DAI评分升高较快,于实验第7天时各模型组DAI评分差异无统计学意义,TNBS组组织学损伤最重,但各造模组之间差异无统计学意义。结论三种造模方法均可以成功诱导大鼠实验性结肠炎模型,各造模组DAI评分和组织学损伤没有显著的差异。DSS造模方法具有较高的安全性。 Objective To compare the colitis aninal models induced by DSS, TNBS or OXZ. Methods This study selected several aspects of rats such as the general state, DAI score, and histological injury for evaluation. Results The rat model safety was higher in the DSS group with no death in the whole experiment process, two rats died in the TNBS group and OXZ group, respectively. DAI score rising of the DSS group was faster, but had no prominent differ- ence in all model group in the seventh day of the experiment, the histological injury of the TNBS group was the most se- rious, but no prominent difference was available among all model groups. Conclusion Three model methods can suc- cessfully induce rat experimental colitis models, DAI score and histological injury have no prominent differences. DSS modeling method has high safety.
出处 《胃肠病学和肝病学杂志》 CAS 2013年第12期1221-1224,共4页 Chinese Journal of Gastroenterology and Hepatology
基金 沈阳市科技资助项目(f12-277-1-54)
关键词 实验性结肠炎模型 葡聚糖硫酸钠 三硝基苯磺酸 恶唑酮 Experimental colitis model DSS TNBS OXZ
  • 相关文献

参考文献14

  • 1Jiang XL,Cui HF. An analysis of 10218 ulcerative colitis cases in China[J].World Journal of Gastroenterology,2002,(01):158-161.
  • 2Darfeuille-Michaud A,Boudeau J,Bulois P. High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease[J].Gastroenterology,2004,(02):412-421.doi:10.1053/j.gastro.2004.04.061.
  • 3Bell AJ,Nicholls RJ,Forbes A. Human lymphocyte stimulation with pouchitis flora is greater than with flora from a healthy pouch but is suppressed by metronidazole[J].Gut,2004,(12):1801-1805.
  • 4Oliva-Hemker M,Fiocchi C. Etiopathogenesis of inflammatory bowel disease:the importance of the pediatric perspective[J].Inflammatory Bowel Diseases,2002,(02):112-128.
  • 5Feillet H,Bach JF. Increased incidence of inflammatory bowel disease:the price of the decline of infectious burden[J].Current Opinion in Gastroenterology,2004,(06):560-564.doi:10.1097/00001574-200411000-00010.
  • 6Arseneau KO,Pizarro TT,Cominelli F. Discovering the cause of inflammatory bowel disease:lessons from animal models[J].Current Opinion in Gastroenterology,2000,(04):310-317.
  • 7Cooper HS,Murthy SN,Shah RS. Clinicopathologic study of dextran sulfate sodium experimental murine colitis[J].Laboratory Investigation,1993,(02):238-249.
  • 8Togawa J,Nagase H,Tanaka K. Lactoferrin reduces colitis in rats via modulation of the immune system and correction of cytokine imbalance[J].American Journal of Physiology-Gastrointestinal and Liver Physiology,2002,(01):G187-G195.
  • 9Lamprecht A,Yamamoto H,Takeuchi H. Nanoparticles enhance therapeutic efficiency by selectively increased local drug dose in experimental colitis in rats[J].Journal of Pharmacology and Experimental Therapeutics,2005,(01):196-202.
  • 10Hamamoto N,Maemura K,Hirata I. Inhibition of dextran sulphate sodium (DSS)-induced colitis in mice by intracolonically administered antibodies against adhesion molecules (endothelial leucocyte adhesion molecule-1 (ELAM-1) or intercellular adhesion molecule-1 (ICAM-1[J].Clinical and Experimental Immunology,1999,(03):462-468.doi:10.1046/j.1365-2249.1999.00985.x.

同被引文献91

引证文献11

二级引证文献82

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部